Session Details

Session Details

03:45 PM - 05:30 PM - Room 307-308

Sarwish Rafiq - PhD - Emory University

Co-Chair

03:45 PM - 05:30 PM - Room 307-308

Charles Gersbach - PhD - Duke University

Co-Chair

03:45 PM - 04:00 PM - Room 307-308

Hong Qin - Mayo Clinic Jacksonville

184: Innovative Applications of CAR T-Cell Therapy in Organ Transplant Patients

04:00 PM - 04:15 PM - Room 307-308

Christian McRoberts Amador - Duke University

185: Discovering Novel Transcriptional Regulators of T Cell Exhaustion for Epigenetic Reversal of T Cell Dysfunction

04:15 PM - 04:30 PM - Room 307-308

Tomer Rotstein - Duke University

186: T-Cell Epigenetic Reprogramming with TGIF2LX-Overexpression Enhances Adoptive Cell Therapy

04:30 PM - 04:45 PM - Room 307-308

Brandon Simone - PhD - University of Pennsylvania

187: Identification of Exhaustion-Associated Genes by Non Viral Editing of Human CD8+ T Cells

04:45 PM - 05:00 PM - Room 307-308

Amanda Chen - The Peter MacCallum Cancer Centre

188: CRISPR Engineering of Armoured CAR T Cells Enables Tumour-Restricted Payload Delivery with Enhanced Safety and Efficacy

05:00 PM - 05:15 PM - Room 307-308

Nora Yucel - PhD - Verismo Therapeutics

189: Preclinical Specificity and Potency Evaluation of a Novel CD19-Specific KIR-CAR T Cell Therapy (SynKIR-310)

05:15 PM - 05:30 PM - Room 307-308

Karina Krotova - Ph.D. - Imanis Life Sciences

190: In Vivo Generation of αCD19-CAR T Cells Using a Novel LV-based Platform Successfully Clears Advanced NALM-6 Tumor without Noticeable Toxicity